20
total announcements
CORALAB.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹202 Cr
P/E (TTM)
10.5
P/E (Forward)
9.7
EPS (TTM)
₹53.76
52W Low
₹360.00
52W High
₹679.00
Dividend Yield
0.37%
Beta
0.85
Price / Book
1.0
Debt / Equity
2.1
Revenue (TTM)
₹97 Cr
Gross Margin
58.16%
Operating Margin
16.28%
Coral Laboratories Ltd
Coral Laboratories Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the voting results and scrutinizer report for its 44th Annual General Meeting (AGM) held on September 30, 2026. All resolutions were passed with the requisite majority.
Coral Laboratories Ltd
Coral Laboratories Ltd held its 44th Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The meeting was attended by 20 members, and the company declared a final dividend for the financial year ended March 31, 2026. The company also re-appointed two directors and ratified the remuneration of the cost auditor.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the closure of its trading window for all designated persons and their relatives from October 1, 2026, till 48 hours after the declaration of unaudited standalone financial results for the quarter and half year ending on September 30, 2026.
Coral Laboratories Ltd
Coral Laboratories Ltd has approved the Cost Audit Report in CRA-3 for the financial year 2025-26, as per the Board of Directors' meeting held on September 25, 2026.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced its annual report for the financial year 2025-26, along with a notice convening the 44th Annual General Meeting (AGM) scheduled for September 29, 2026. The report includes the audited standalone financial statements for the year ended March 31, 2026, and the reports of the board of directors and auditors.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the 44th AGM scheduled for September 29, 2026, to consider and adopt the audited standalone financial statements for the financial year ended March 31, 2026.
Coral Laboratories Ltd
Coral Laboratories Ltd has published a newspaper advertisement regarding its 44th Annual General Meeting, book closure, and dividend information, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced a notice of book closure for its 44th Annual General Meeting (AGM) to be held on September 29, 2026, through video conferencing. The book closure dates are September 23-22, 2026, for the purpose of final dividend.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the convening of its 44th Annual General Meeting (AGM) on September 29, 2026, through video conferencing. The notice and annual report will be shared in due course.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 538.81 lakhs and earnings per share of Rs. 15.08.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the record date for its final dividend and book closure date for the 44th Annual General Meeting.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced its standalone unaudited financial results for the quarter ended June 30, 2026, showing a profit from continuing operations of Rs. 538.81 lakhs. The company has also announced the 44th Annual General Meeting to be held on September 29, 2026.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced that shares will be transferred to the Investor Education and Protection Fund (IEPF) due to non-receipt of dividend for 7 consecutive years. The company has published a notice in newspapers as required by SEBI regulations.
Coral Laboratories Ltd
Coral Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 14, 2026, to consider and approve standalone unaudited financial results for the quarter ended June 30, 2026, and other business.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the results of its postal ballot e-voting, with a resolution to approve an increase in remuneration and other facilities to Ms. Meera Doshi passed with 63.39% of votes in favor and 36.61% against.
Coral Laboratories Ltd
Coral Laboratories Ltd has announced the outcome of its postal ballot, where a resolution to increase the remuneration and other facilities of Ms. Meera Doshi has been passed with 63.39% of votes in favor and 36.61% against.
Coral Laboratories Ltd
Coral Laboratories Ltd. announced the publication of newspaper notices regarding the dispatch of its Postal Ballot Notice dated June 18, 2026, and remote e-voting instructions. These notices were published on June 23, 2026, in The Free Press Journal (English) and Nav Shakti (Marathi). This disclosure is made in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, and the information is also available on the company's website.
Coral Laboratories Ltd
Coral Laboratories Ltd announced the closure of its trading window for all Designated Persons and their relatives. This action, effective from July 1, 2026, is taken to comply with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will reopen 48 hours after the declaration of the unaudited standalone financial results for the quarter ending June 30, 2026, the date for which will be intimated separately.
Coral Laboratories Ltd
Coral Laboratories Ltd has issued a postal ballot notice to shareholders seeking approval for an increase in remuneration and other facilities for Ms. Meera Doshi, Head of Business Strategy. The proposed remuneration is up to ₹6,50,000 per month, along with additional benefits. This proposal, falling under related party transactions, requires an Ordinary Resolution from shareholders via e-voting. The e-voting period is from June 23, 2026, to July 22, 2026, with results expected by July 23, 2026.